Malta - Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes

Since 2014, Malta Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes was up 7.8% year on year. In 2019, the country was ranked number 18 comparing other countries in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes with €183.44 Per Capita. Malta is overtaken by Slovakia, which was ranked number 17 at €196.26 Per Capita and is followed by Slovenia at €168.24 Per Capita. Switzerland lead the ranking with €666.37 Per Capita in 2019, an increase of 3.2% compared to 2018. Germany, Liechtenstein and Ireland respectively ranked number 2, 3 and 4 in this ranking. Latvia witnessed the best average annual growth at +8.8% per year, while Romania recorded the worst performance at -1.7% per year.

Loading...

Date Euros Per Capita
2019 183.44
2018 181.67
2017 178.06
2016 147.67
2015 131.33
Download all data from 2014 to 2019

How does Malta rank in Healthcare Expenditure on Pharmaceuticals and Medical Non-Durable Goods by Government Schemes and Compulsory Contributory Health Care Financing Schemes?

# 33 Countries Euros Per Capita Last YoY 5‑years CAGR
1 #1
Switzerland
666.37 2019 +3.1 % +5.3 % View data
2 #2
Germany
553.39 2019 +2.3 % +3.0 % View data
17 #17
Slovakia
196.26 2019 +0.8 % +0.9 % View data
18 #18
Malta
183.44 2019 +1.0 % +7.8 % View data
19 #19
Slovenia
168.24 2019 -0.5 % +4.0 % View data
Compare all 33 countries

Go Top